Join to View Full Profile
701 Hewitt BlvdRed Wing, MN 55066
Phone+1 651-267-5000
Fax+1 651-267-5908
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Meyer, MD is a board certified internist in Red Wing, Minnesota. He is currently licensed to practice medicine in Minnesota, Wisconsin, and North Dakota.
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1991 - 1994
Philipps University of Marburg Faculty of MedicineClass of 1988
Certifications & Licensure
WI State Medical License 2011 - 2027
MN State Medical License 2003 - 2026
ND State Medical License 1994 - 2003
PA State Medical License 1994 - 1996
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Access Profiler Enterprise, EMRConnect, 2012-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification Access Profiler Enterprise, EMRConnect, 2012-2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2012-2014, 2016-2017
Publications & Presentations
PubMed
- 12 citationsTofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.Jochen H Weishaupt, Péter Körtvélyessy, Peggy Schumann, Ivan Valkadinov, Ute Weyen
Communications Medicine. 2024-07-25 - 12 citationsSafety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.Merit Cudkowicz, Angela Genge, Nicholas J. Maragakis, Susanne Petri, Leonard H. van den Berg
The Lancet. Neurology. 2021-10-01 - 33 citationsTIFA has dual functions in Helicobacter pylori-induced classical and alternative NF-κB pathways.Gunter Maubach, Michelle Chin Chia Lim, Olga Sokolova, Steffen Backert, Thomas F. Meyer
EMBO Reports. 2021-09-06
